CompletedPhase 2NCT01585402

Etidronate for Arterial Calcifications Due to Deficiency in CD73 (ACDC)

Studying Hereditary arterial and articular multiple calcification syndrome

Last synced from ClinicalTrials.gov May 10, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Principal Investigator: Alessandra Brofferio, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Intervention: Etidronate(drug)
Enrollment: 7 enrolled
Eligibility: 18-80 years · All sexes
Timeline: 2012 – 2021

Study locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01585402 on ClinicalTrials.gov

← Back to all trials